Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV

Qerqez, Ahlam N., Hoffmann, Katja, Lee, Alison G., Pareek, Sumit, Hager, Kelli, Mishra, Akaash K., Delidakis, George, Bentley, Kirsten ORCID: https://orcid.org/0000-0002-6619-2098, Kerr-Jones, Lauren, Cabrera, Mica, Nguyen, Truong, Göttler, Rebecca L., Chowdhury, Amjad, Kolb, Philipp L., Hengel, Hartmut, Georgiou, George, McLellan, Jason S., Stanton, Richard J. ORCID: https://orcid.org/0000-0002-6799-1182, Nguyen, Annalee W. and Maynard, Jennifer A. 2025. Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV. Cell Reports 44 (12) , 116593. 10.1016/j.celrep.2025.116593

PDF - Published Version Available under License Creative Commons Attribution. Download (5MB)

Abstract

Antibodies binding cell-surface antigens to activate cellular immunity are an important mechanism of anti-viral protection, yet antibodies targeting cells infected by human cytomegalovirus (HCMV) exhibit limited efficacy. This is due to HCMV immune evasion mechanisms, including viral receptors (vFcγRs) that bind human immunoglobulin G Fc domains to inhibit host Fcγ receptor activation and impair Fc-mediated immune functions. Here, we biochemically characterize two conserved vFcγRs, gp34 and gp68, and map their Fc binding sites. We then engineer Fc variants to retain binding to host Fc receptors CD16A and FcRn but exhibit markedly reduced gp34/gp68 interactions. Antibodies targeting the gB fusogen with engineered Fc domains are not internalized by infected cells, mediate enhanced immune cell activation, and limit viral spread in HCMV-infected fibroblasts more effectively than antibodies with wild-type Fc. This work demonstrates a strategy to enhance therapeutic antibody control of HCMV infections and other herpesvirus infections with similar immune-evasion mechanisms.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Systems Immunity Research Institute (SIURI)
Publisher:	Cell Press
ISSN:	2211-1247
Funders:	Wellcome
Date of First Compliant Deposit:	5 December 2025
Date of Acceptance:	3 November 2025
Last Modified:	05 Dec 2025 09:45
URI:	https://orca.cardiff.ac.uk/id/eprint/182931

Actions (repository staff only)

Edit Item